<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Cardioplegia in pediatric cardiac surgery: do we believe in magic?
2
Cardioplegia preserves hypoxic response in isolated coronary arteries but not in isolated hearts
3
Cardioplegia protection against ischemia-reperfusion failure: Role of both modes of Na/Ca-exchanger and sarcoplasmic reticulum  
4
Cardioplegia-induced cell swelling: prevention by normothermic infusion
5
Cardioplegic arrest with image-arginine improves myocardial protection: results of a prospective randomized clinical trial
6
Cardioplegic ischemia or reperfusion: Which is a main trigger for tumor necrosis factor production?
7
Cardiopoiesis: Cardiac myocyte creation by adult and embryonic cells
8
Cardiopoietic Stem Cell Therapy in Heart Failure: The C-CURE (Cardiopoietic stem Cell therapy in heart failURE) Multicenter Randomized Trial With Lineage-Specified Biologics
9
Cardiopoietry in Motion: Primed Mesenchymal Stem Cells for Ischemic Cardiomyopathy
10
Cardioprotection and garlic
11
Cardioprotection and garlic
12
Cardioprotection and garlic
13
Cardioprotection and garlic
14
Cardioprotection and mitochondrial S-nitrosation: Effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia–reperfusion injury
15
Cardioprotection at a Distance: Mesenteric Artery Occlusion Protects the Myocardium via an Opioid Sensitive Mechanism
16
Cardioprotection before revascularization in ischemic myocardial injury and the potential role of hemoglobin-based oxygen carriers
17
Cardioprotection by 3-iodothyronamine, a new endogenous chemical messenger
18
Cardioprotection by Activation of NO/cGMP Pathway After Cardioplegic Arrest and 8-Hour Storage
19
Cardioprotection by Cyclosporine A in Experimental Ischemia and Reperfusion—Evidence for a Nitric Oxide-dependent Mechanism Mediated by Endothelin
20
Cardioprotection by Ischemic Preconditioning Preserves Mitochondrial Function and Functional Coupling Between Adenine Nucleotide Translocase and Creatine Kinase
21
Cardioprotection by Local Heating: Improved Myocardial Salvage After Ischemia and Reperfusion
22
Cardioprotection by Orotic Acid: Metabolism and Mechanism of Action
23
Cardioprotection by Volatile Anesthetics in Noncardiac Surgery? No, Not Yet At Least
24
Cardioprotection During Chemotherapy: Need for Faster Transfer of Knowledge From Cardiology to Oncology and Role for a Cardio-Oncologist
25
Cardioprotection Effects of Sevoflurane by Regulating the Pathway of Neuroactive Ligand-Receptor Interaction in Patients Undergoing Coronary Artery Bypass Graft Surgery
26
Cardioprotection for Duchenne’s muscular dystrophy, ,
27
Cardioprotection from ischaemia–reperfusion injury: Dissecting the PI3K/AKT pathway with chemical inhibition of PTEN
28
Cardioprotection in aged myocardium: Sites of failure in protective signalling
29
Cardioprotection induced in response to preconditioning is lost after an initral iscraemic insult
30
Cardioprotection of bradykinin at reperfusion in isolated rat hearts requires a transactivation of the EGF receptor
31
Cardioprotection of trimetazidine and anthracycline-induced acute cardiotoxic effects
32
Cardioprotection with phosphodiesterase-5 inhibition—a novel preconditioning strategy
33
Cardioprotection: A New Paradigm in the Management of Acute Heart Failure Syndromes
34
Cardioprotection: Intermittent Ventricular Fibrillation and Rapid Pacing Can Induce Preconditioning in the Blood-perfused Rat Heart
35
Cardioprotective Actions of Verapamil on theβ-Adrenergic Receptor Complex in Acute Canine Chagasʹ Disease
36
Cardioprotective activity of melatonin and its novel synthesized derivatives on doxorubicin-induced cardiotoxicity Original Research Article
37
Cardio-protective and anti-cancer therapeutic potential of Nigella sativa
38
Cardioprotective and antioxidant activities of a polysaccharide from the root bark of Aralia elata (Miq.) Seem
39
Cardioprotective and Anti-oxidant Effects of the Terpenoid Constituents ofGinkgo bilobaExtract (EGb 761)
40
Cardio-protective and cholesterol lowering effects of garlic (Allium sativum) and ginger (Zingiber officiale) extracts in laboratory animals
41
Cardioprotective and Hepatoprotective Activity of Silymarin in Broiler Chickens Fed on Mash and Pellet Diets
42
Cardioprotective and neuroprotective roles of oleuropein in olive
43
Cardioprotective and neuroprotective roles of oleuropein in olive
44
Cardioprotective Effect by Tumor Necrosis Factor-α and Interleukin-6 through Late Preconditioning in Unstable Angina Patients
45
Cardioprotective effect of aqueous extract of Chichorium intybus L. on ischemia-reperfusion injury in isolated rat heart
46
Cardioprotective effect of Azadirachta indica A. Juss. on isoprenaline induced myocardial infarction in rats
47
Cardioprotective Effect of Beta-3 Adrenergic Receptor Agonism: Role of Neuronal Nitric Oxide Synthase
48
Cardioprotective effect of cedrol in an inflammation systemic model induced by lipopolysaccharide: Biochemical and histological verification
49
Cardioprotective effect of chronic hypoxia is blunted by hypercapnia
50
Cardioprotective effect of chronic low dose ethanol drinking: Insights into the concept of ethanol preconditioning
51
Cardioprotective Effect of Cold-Blood Cardioplegia Enriched with N-Acetylcysteine During Coronary Artery Bypass Grafting
52
Cardioprotective effect of diazepam on ischemia-reperfused isolated hyperthyroid rat heart
53
Cardioprotective Effect of Ethanolic Leaf Extract of Melissa Officinalis L Against Regional Ischemia-Induced Arrhythmia and Heart Injury after Five Days of Reperfusion in Rats
54
Cardioprotective Effect of Extended Remote Ischemic Preconditioning in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Clinical Trial
55
Cardioprotective effect of fasting on ischemia reperfused rat heart after diazepam administration
56
Cardioprotective Effect of Garlic Juice on the Isolated Rat Heart in Ischemia- Reperfusion
57
Cardioprotective Effect of Glucagon Like Peptide-1 Receptor During Reperfusion of Isolated Ischemic Rat Heart Involves AMP-Activated Protein Kinase (AMPK) and Akt Signaling Pathways
58
Cardioprotective Effect of Grape Seed Extract on Chronic Doxorubicin-Induced Cardiac Toxicity in Wistar Rats
59
Cardioprotective effect of grape seed proanthocyanidins on isoproterenol-induced myocardial injury in rats
60
Cardioprotective effect of growth hormone secretagogues in rat heart
61
Cardioprotective Effect of High Intensity Interval Training and Nitric Oxide Metabolites (NO2-, NO3-)
62
Cardioprotective Effect of High-Intensity Aerobic Interval Training against Adriamycin-Induced Cardiac Toxicity in Rats
63
Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats
64
Cardioprotective effect of lipstatin derivative orlistat on normotensive rats submitted to cardiac ischemia and reperfusion
65
Cardioprotective effect of preconditioning is more efficient than postconditioning in rats submitted to cardiac ischemia and reperfusion
66
Cardioprotective Effect of Quercetin against Ischemia/Reperfusion Injury Is Mediated Through NO System and Mitochondrial KATP Channels
67
Cardioprotective effect of Rosa canina L. methanolic extract on heat shock induced cardiomyocyte injury: An experimental study
68
Cardioprotective effect of royal jelly on paclitaxel-induced cardio-toxicity in rats
69
Cardioprotective Effect of Saffron Extract and Safranal in Isoproterenol-Induced Myocardial Infarction in Wistar Rats
70
Cardioprotective effect of selenium via modulation of cardiac ryanodine receptor calcium release channels in diabetic rat cardiomyocytes through thioredoxin system
71
Cardioprotective effect of vanillic acid against doxorubicin-induced cardiotoxicity in rat
72
CARDIOPROTECTIVE EFFECTS AND MECHANISM OF ACTION OF POLYPHENOLS EXTRACTED FROM PROPOLIS AGAINST DOXORUBICIN TOXICITY
73
Cardioprotective effects and molecular mechanisms of G-CSF on LV remodeling and dysfunction after AMI
74
Cardioprotective Effects of 17β-Estradiol Produced by Activation of Mitochondrial ATP-Sensitive K+Channels in Canine Hearts
75
Cardioprotective effects of a proanthocyanidin-rich fraction from Croton celtidifolius Baill: Focus on atherosclerosis
76
Cardioprotective effects of an early invasive strategy for non–ST-segment elevationacute coronary syndromes: Are we all becoming “interventional” cardiologists?
77
Cardioprotective effects of atorvastatin plus trimetazidine in percutaneous coronary intervention
78
Cardioprotective effects of bosentan, a mixed ETA/ETB Receptor antagonist on myocardial ischemic and reperfusion injury in cats
79
Cardioprotective effects of co-administration of thymoquinone and ischemic postconditioning in diabetic rats
80
Cardioprotective Effects of Coenzyme Q10 Supplementation on Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
81
Cardioprotective Effects of Curcumin Co-treatment in Rats With Establishing Chronic Variable Stress Stereology Study
82
Cardioprotective Effects of Essential Oil of Lavandula angustifolia on Isoproterenol-induced Acute Myocardial Infarction in Rat
83
Cardioprotective effects of Fenugreek (Trigonella foenum-graceum) seed extract in streptozotocin induced diabetic rats
84
Cardioprotective effects of FK409, a nitric oxide donor, after isolated rat heart preservation for 16 hours
85
Cardioprotective effects of Ganoderma lucidum on isoproterenol–induced heart failure
86
Cardioprotective effects of granulocyte colony-stimulating factor in swine with chronic myocardial ischemia
87
Cardioprotective Effects of Granulocyte Colony-Stimulating Factor in Swine With Chronic Myocardial Ischemia Original Research Article
88
Cardioprotective Effects of Grape Seed Proanthocyanidin Against Ischemic Reperfusion Injury
89
Cardioprotective effects of Ilex paraguariensis extract: evidence for a nitric oxide-dependent mechanism
90
Cardioprotective effects of iroxanadine: Role of nitric oxide, reactive oxygen species and heat-shock proteins
91
cardioprotective effects of mebudipine in a rat model of doxorubicin-induced heart failure
92
Cardioprotective Effects of Methanolic Extract of Scrophularia frigida on Ischemia-Reperfusion-Induced Injuries in Isolated Rat Heart
93
cardioprotective effects of octreotide against sepsis-induced cardiotoxicity in mice
94
Cardioprotective effects of pharmacologic preconditioning by natural honey against ischemia/reperfusion injury
95
Cardioprotective effects of pomegranate juice against ischemia and reperfusion in isolated rat heart
96
Cardioprotective Effects of Potassium Channel Openers on Rat Atria and Isolated Hearts under Acute Hypoxia
97
Cardioprotective effects of preinfarction angina in elderly: same patients, different results?
98
Cardioprotective Effects of Rosmarinic Acid on IsoproterenolInduced Myocardial Infarction in Rats
99
Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention
100
Cardioprotective effects of the NHE1-inhibitor EMD 87580
101
Cardioprotective efficacy of ischemic preconditioning on long-term myocardial ischemia
102
Cardioprotective Function of Inducible Nitric Oxide Synthase and Role of Nitric Oxide in Myocardial Ischemia and Preconditioning: an Overview of a Decade of Research
103
Cardioprotective mechanisms of sour cherry seed extract against ischemia/reperfusion-induced damage in isolated rat hearts  
104
Cardioprotective Medication Is Associated With Improved Survival in Patients With Peripheral Arterial Disease Original Research Article
105
Cardioprotective Potential of Antihypertensives
106
Cardioprotective potential of biobased gold nanoparticles
107
Cardioprotective Potential of Celastrol in Sepsis-Induced Cardiotoxicity; Mouse Model of Endotoxemia
108
Cardioprotective Potential of Gemmomodified Extract of Terminalia arjuna against Chemically Induced Myocardial Injury in Rabbits
109
Cardio-protective properties of Momordica charantia in Albino Rats
110
Cardioprotective role of biosynthesized gold nanoparticles compared to an iodinated-based x-ray contrast agent in Male Wistar Rats
111
Cardioprotective role of FGF2 in a murine model of low-flow ischemia  
112
Cardio-Protective Role of Gingerol along with Prominent Anti-Diabetic Cardiomyopathy Action in A Streptozotocin-Induced Diabetes Mellitus Rat Model StreptozotocinInduced Diabetes Mellitus Rat Model
113
Cardioprotective therapy and sodium-hydrogen exchange inhibition: current concepts and future goals
114
Cardiopulmonary and Systemic Effects of Methylprednisolone in Patients Undergoing Cardiac Surgery
115
Cardiopulmonary Arrest Outcome in Nemazee Hospital, Southern Iran
116
CARDIOPULMONARY ARREST SECONDARY TO HALOPERIDOL
117
CARDIO-PULMONARY ASSESSMENT IN PATIENTS WITH BETA THALASSEMIA
118
Cardiopulmonary bypass affects cognitive brain function after coronary artery bypass grafting
119
Cardiopulmonary Bypass Alone Does Not Cause Postoperative Cognitive Dysfunction Following Open Heart Surgery
120
Cardiopulmonary bypass alters vasomotor regulation of the skeletal muscle microcirculation
121
Cardiopulmonary bypass and oxygen consumption: oxygen delivery and hemodynamics
122
Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans
123
Cardiopulmonary Bypass Circuit Treated With Surface-Modifying Additives: A Clinical Evaluation of Blood Compatibility
124
Cardiopulmonary bypass during pregnancy
125
Cardiopulmonary bypass for resuscitation after penetrating cardiac trauma
126
Cardiopulmonary bypass in a gravid patient: perioperative changes in endothelin levels
127
Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant
128
Cardiopulmonary bypass in humans: bypassing unfractionated heparin
129
Cardiopulmonary bypass in man: role of the intestine in a self-limiting inflammatory response with demonstrable bacterial translocation
130
Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis
131
Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using org 10172
132
Cardiopulmonary bypass in pregnancy
133
Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases
134
Cardiopulmonary bypass perfusion temperature does not influence perioperative renal function
135
Cardiopulmonary bypass support for emergency cesarean delivery in a patient with severe pulmonary hypertension
136
Cardiopulmonary bypass temperature, hematocrit, and cerebral oxygen delivery in humans
137
Cardiopulmonary Bypass Time Does Not Affect Cerebral Blood Flow
138
Cardiopulmonary Bypass With Bivalirudin in Type II Heparin-Induced Thrombocytopenia
139
Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia
140
Cardiopulmonary Bypass With Heparin-Coated Circuits and Reduced Systemic Anticoagulation
141
Cardiopulmonary Bypass, Inflammation and How to Defy it: Focus on Pharmacological Interventions
142
Cardiopulmonary bypass, rewarming, and central nervous system dysfunction
143
Cardiopulmonary bypass: Perioperative cerebral blood flow and postoperative cognitive deficit
144
Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital
145
Cardiopulmonary effects of Detomidine-Propofol and Ketamine administration in the Donkeys
146
Cardiopulmonary effects of dorsal recumbency and high-volume caudal epidural anaesthesia with lidocaine or xylazine in calves
147
Cardiopulmonary effects of HI-6 treatment in soman intoxication
148
Cardiopulmonary effects of the anesthesia by romifidine as a premedication, midazolam and ketamine induction and infusion in donkeys
149
Cardiopulmonary effects of the laparoscopic pneumoperitoneum in a porcine model of adult respiratory distress syndrome
150
Cardiopulmonary exercise parameters in relation to all-cause mortality in patients with chronic heart failure
151
Cardiopulmonary exercise test evidence of isolated right coronary artery disease
152
Cardiopulmonary Exercise Test in Advanced Heart Failure Among Heart Transplantation Candidates
153
Cardiopulmonary exercise test in patients with subacute pulmonary emboli
154
Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited
155
Cardiopulmonary Exercise Testing and Six-Minute Walk Correlations in Pulmonary Arterial Hypertension
156
Cardiopulmonary exercise testing before and one year after mitral valve repair for severe mitral regurgitation
157
Cardiopulmonary Exercise Testing Determination of Functional Capacity in Mitral Regurgitation: Physiologic and Outcome Implications Original Research Article
158
Cardiopulmonary Exercise Testing Identifies Low Risk Patients With Heart Failure and Severely Impaired Exercise Capacity Considered for Heart Transplantation
159
Cardiopulmonary exercise testing in patients with heart failure
160
Cardiopulmonary Exercise Testing in the Clinical and Prognostic Assessment of Diastolic Heart Failure Original Research Article
161
Cardiopulmonary Exercise Variables in Diastolic Versus Systolic Heart Failure
162
Cardiopulmonary Function at Rest and During Exercise After Resection for Bronchial Carcinoma
163
Cardiopulmonary function in adult patients late after Fontan repair
164
Cardiopulmonary Functions of School Children in Oil-Spilled and Gas-Flared Niger- Delta and Rural-Riverine Lagos Communities
165
Cardiopulmonary hazards of perihepatic packing for major liver injuries,
166
Cardiopulmonary helminth parasites of red foxes (Vulpes vulpes) in Catalonia, northeastern Spain
167
Cardiopulmonary Limited Ultrasound Examination for “Quick-Look” Bedside Application
168
Cardiopulmonary Mortalities and Chronic Obstructive Pulmonary Disease Attributed to Ozone Air Pollution
169
Cardiopulmonary Mortalities and Chronic Obstructive Pulmonary Disease Attributed to Ozone Air Pollution
170
Cardiopulmonary mortality and air pollution
171
Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide
172
Cardiopulmonary Rehabilitation for Patients with Coronavirus Disease 2019 (COVID-19): A Narrative Review
173
Cardiopulmonary Response to Exercise and Cardiac Assessment in Patients With Turner Syndrome
174
Cardiopulmonary response to maximal exercise in young athletes following the Ross procedure
175
Cardiopulmonary Responses to Exercise and Its Utility in Patients With Aortic Stenosis
176
Cardiopulmonary responses to robotic end-effector-based walking and stair climbing
177
Cardiopulmonary Resuscitation (CPR) and Its Ethical Aspects
178
CARDIOPULMONARY RESUSCITATION : THE SHORT COMINGS IN MALAYSIA
179
Cardiopulmonary resuscitation and neurological complications in the elderly
180
Cardiopulmonary resuscitation by bystanders with chest compression only (SOS-KANTO): an observational study
181
Cardiopulmonary resuscitation by Emergency Medical Services in South Africa: Barriers to achieving high quality performance
182
Cardiopulmonary resuscitation directives on admission to intensive-care unit: an international observational study
183
Cardiopulmonary resuscitation in nursing homes
184
CARDIOPULMONARY RESUSCITATION IN THE LIGHT OFNEW 2010 AMERICAN HEART ASSOCIATION GUIDELINES: A SURVEY AMONG HEALTHCARE PROFESSIONALS OF TERTIARY CARE HOSPITALS IN PESHAWAR CITY
185
Cardiopulmonary resuscitation knowledge among nursing students: a questionnaire study
186
Cardiopulmonary resuscitation knowledge among nursing students: a questionnaire-based study
187
Cardiopulmonary Resuscitation Outcomes of Patients with COVID-19; a One-Year Survey
188
Cardiopulmonary Resuscitation Techniques and Instruction: When Does Evidence Justify Revision?, ,
189
Cardiopulmonary Resuscitation to Cardiocerebral Resuscitation: Difference Is Small for Statistical Significance but Large for Clinical Relevance
190
cardiopulmonary resuscitation training for medical students in anesthesiology rotation in ardabil medical university (iran)
191
Cardiopulmonary resuscitation with a novel chest compression device in a porcine model of cardiac arrest: Improved hemodynamics and mechanisms Original Research Article
192
Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis
193
Cardiopulmonary Resuscitation, Chest Compression Only and Teamwork From the Perspective of Medical Doctors, Surgeons and Anesthesiologists
194
Cardiopulmonary resuscitation, ventilation, defibrillation: In what order?
195
Cardiopulmonary Resuscitation.J.P. Ornato and M.A. Peberdy, Editors, Humana Press (2005) 764 pages, $185 ISBN 1-58829-283-5.
196
Cardiopulmonary resuscitation: Historical perspective to recent investigations
197
Cardiopulmonary resuscitation: Knowledge and personal experience among dentists in Udaipur, India
198
Cardiopulmonary Safety of Propofol Versus Midazolam/Meperidine Sedation for Colonoscopy: A Prospective, Randomized, Double-Blinded Study
199
Cardiopulmonary-Cerebral Resuscitation (CPCR) Training for Nurses in Iran: A Review Study
200
Cardiorenal and sympathetic effects of leptin in spontaneously hypertensive lean and obese koletsky rats
201
Cardiorenal Anemia Syndrome as a Prognosticator for Death in Heart Failure
202
Cardiorenal Effects of Recombinant Human Natriuretic Peptides
203
Cardiorenal Interactions: Insights From the ESCAPE Trial Original Research Article
204
Cardiorenal Outcomes After Slow Continuous Ultrafiltration Therapy in Refractory Patients With Advanced Decompensated Heart Failure
205
Cardio-Renal Profiling with hs-CRP and its Implications as a Diagnostic Tool in Chronic Kidney Disease Patients.
206
Cardiorenal Protective Effects of Year-Long Antihypertensive Therapy With a Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker in Spontaneously Hypertensive Rats
207
Cardiorenal Syndrome
208
Cardiorenal syndrome
209
Cardiorenal Syndrome Review Article
210
Cardiorenal syndrome followed by acute hepatitis C in a patient with acute myeloid leukemia
211
Cardiorenal Syndrome or Renocardiac Syndrome
212
Cardiorenal Syndrome Type 1: Pathophysiological Crosstalk Leading to Combined Heart and Kidney Dysfunction in the Setting of Acutely Decompensated Heart Failure
213
Cardio-renal-anemia syndrome: a report of three cases
214
Cardiorespiratory and all-cause mortality after restrictions on sulphur content of fuel in Hong Kong: an intervention study
215
Cardiorespiratory and neuroendocrine changes induced by methadone in conscious and in isoflurane anaesthetised dogs
216
Cardiorespiratory and thermoregulatory effects of endophyte-infected fescue in exercising horses
217
Cardiorespiratory challenges in Rettʹs syndrome
218
Cardiorespiratory changes during upper gastrointestinal endoscopy
219
Cardio-respiratory control during early development in the model animal zebrafish
220
Cardio-respiratory coupling in untreated patients with major depression
221
CARDIORESPIRATORY CRISIS AT THE END OF PREGNANCY: A CASE OF PHEOCHROMOCYTOMA
222
Cardiorespiratory effects of epidurally administered ketamine or lidocaine in dogs undergoing ovariohysterectomy surgery: a comparative study
223
Cardiorespiratory Fitness and Body Composition of Soccer Referees; Do These Correlate With Proper Performance?
224
Cardiorespiratory fitness and coronary heart disease risk factor association in women
225
Cardiorespiratory Fitness and Its Relationship with Health Risk Factors Among University Students: A Comparison Between Iran and Italy
226
Cardiorespiratory Fitness and Metabolic Risk
227
Cardiorespiratory Fitness and Physical Literacy: Exploring the Nexus. A Scoping Review
228
Cardiorespiratory Fitness and Risk of Nonfatal Cardiovascular Disease in Women and Men With Hypertension
229
Cardiorespiratory fitness and risk of prostate cancer: Findings from the Aerobics Center Longitudinal Study
230
Cardiorespiratory Fitness and the Attenuation of Age-Related Rise in Blood Pressure: An Important Role for Effective Primordial Prevention
231
Cardiorespiratory Fitness as a Correlate of Cardiovascular, Anthropometric, and Physical Risk Factors: Using the Ruffier Test as a Template
232
Cardiorespiratory Fitness as Criterion Validity for Health-Based Metabolic Syndrome Definition in Adolescents
233
Cardiorespiratory Fitness Is Related to the Risk of Sudden Cardiac Death: A Population-Based Follow-Up Study
234
Cardio-respiratory fitness markers among Kenyan university students using a 20m shuttle run test (SRT)
235
Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men
236
Cardiorespiratory Parameters in Intermittent Positive Pressure Ventilation Versus Spontaneous Ventilation in Under One-Year-Old Pediatrics: A Randomized Trial
237
Cardiorespiratory reflexes in a working heart–brainstem preparation of the house musk shrew, Suncus murinus
238
Cardiorespiratory response during exercise in patients with cyanotic congenital heart disease with and without a Fontan operation and in patients with congestive heart failure
239
Cardiorespiratory Response to Exercise After Modified Fontan Operation: Determinants of Performance
240
Cardiorespiratory Response to Exercise After Renal Sympathetic Denervation in Patients With Resistant Hypertension
241
Cardiorespiratory responses to exercise after repair of the univentricular heart
242
Cardiorespiratory Responses to Glittre ADL Test in Bronchiectasis: A Cross-Sectional Study
243
Cardiorespiratory responses to negative pressure ventilation after tetralogy of Fallot repair: hemodynamic tool for patients with low-output state
244
Cardiorespiratory Responses to Table Tennis in Low-Fit Coronary Patients and Implications for Exercise Training
245
Cardiorotective effects of a novel indole derivative with antioxidant properties against ischemic reperfusion injury
246
Cardioscopic guidance of linear lesion creation for radiofrequency ablation
247
Cardioscopic spectrum of the left ventricular endocardial surface and its relation to histologic changes in idiopathic myocarditis
248
CardioSEAL/STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defects
249
CardioSignal: A database of transcriptional regulation in cardiac development and hypertrophy
250
Cardiosource is a good source for definition of trial acronyms
251
Cardiospermum halicacabum Linn.: Food and Drug
252
Cardiothoracic Surgeons Divided By a Common Language
253
Cardiothoracic surgery in the new millennium: challenges and opportunities in a time of paradox
254
Cardiothoracic Surgery Resident Education: Update on Resident Recruitment and Job Placement
255
Cardiothoracic Surgery, 2nd Edition: by Fritz J. Baumgartner, MD, Georgetown, Texas, Landes Bioscience, 1999, 280 pages, spiral bound, $45, ISBN: 1-570-59559-3
256
Cardiothoracic surgery: a specialty in transition—good to great?
257
Cardiotin localization in mitochondria of cardiomyocytes in vivo and in vitro and its down-regulation during dedifferentiation
258
Cardiotocography and medicolegal issues
259
Cardiotocography in the Prognosis of Perinatal Outcome
260
Cardiotocography only versus cardiotocography plus PR-interval analysis in intrapartum surveillance: a randomised, multicentre trial Original Research Article
261
Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial
262
Cardiotocography Waveform Analysis Using Image Extraction Technique
263
Cardiotomy Suction: A Major Source of Brain Lipid Emboli During Cardiopulmonary Bypass
264
Cardiotonic activity of methanolic extract of Saussurea lappa Linn roots
265
Cardiotonic Drugs from the Avicenna's Point of View
266
Cardiotonic Modulation in Heart Failure: Insights From Traditional Chinese Medicine
267
Cardiotoxic and Arrhythmogenic Effects of Hemiscorpius lepturus Scorpion Venom in Rats
268
Cardiotoxic Effects of Hemiscorpius Lepturus Scorpion Venom Fractions in Rats
269
Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy
270
Cardiotoxicité de l’association trastuzumab–radiothérapie mammaire : une étude prospective monocentrique
271
Cardiotoxicité de l’association trastuzumab–radiothérapie mammaire : une étude prospective monocentrique
272
Cardiotoxicity associated with sunitinib
273
Cardiotoxicity associated with sunitinib
274
Cardiotoxicity associated with sunitinib – Authorsʹ reply
275
Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer
276
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
277
Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors
278
Cardiotoxicity of 5-flourouracil: two case reports
279
Cardiotoxicity of cytotoxic drugs
280
Cardiotoxicity of Plants in Iran: a Review
281
Cardiotoxicity of Senna occidentalis in sheep (Ovis aries)
282
Cardiotoxicity Research in Breast Cancer Patients: Past and Future
283
Cardiotoxicity With 5-Fluorouracil Based Agents: Rechallenge Cannot Currently Be Safely Advised
284
Cardiotoxicity with adjuvant trastuzumab use in breast cancer: A single institution’s experience
285
Cardiotrophin-1 in Patients with Acute Myocardial Infarction
286
Cardiotrophin-1 Induces Heat Shock Protein Accumulation in Cultured Cardiac Cells and Protects them from Stressful Stimuli
287
Cardiotrophin-1 induces proliferation and activation of primary adult rat cardiac fibroblasts  
288
Cardiotrophin-1 is a prophylactic against the development of chronic hypoxic pulmonary hypertension in rats
289
Cardiotrophin-1 Phosphorylates Akt and BAD, and Prolongs Cell Survival via a PI3K-dependent Pathway in Cardiac Myocytes
290
Cardiotrophin-1 regulates osteoclast and osteoblast function in a manner distinct from other gp130 cytokines
291
Cardiovacular and cerebrovacular mortality aociated with ocular peudoexfoliation
292
Cardiovacular Dieae, it Rik Factor and Treatment, and Age-related Macular Degeneration: Women’ Health Initiative ight Exam Ancillary tudy
293
Cardiovacular Dieae, it Rik Factor and Treatment, and Age-related Macular Degeneration: Women’ Health Initiative ight Exam Ancillary tudy Original Reearch Article
294
Cardiovacular Rik Factor and Age-related Macular Degeneration: The Lo Angele Latino Eye tudy Original Reearch Article
295
Cardiovascular Abnormalities in Cirrhosis: the Possible Mechanisms
296
Cardiovascular abnormalities in hyperthyroidism
297
Cardiovascular Abnormalities in Hyperthyroidism
298
Cardiovascular Abnormalities in Hyperthyroidism
299
Cardiovascular abnormalities in hyperthyroidism: A prospective Doppler echocardiographic study
300
Cardiovascular abnormalities in never-treated hypertensives according to nondipper status
301
Cardiovascular Abnormalities in Sickle Cell Disease
302
Cardiovascular activity and the antibody response to vaccination
303
Cardiovascular adaptations to endurance training and detraining in young and older athletes
304
Cardiovascular aging and psychometric performances: correlations in a group of ultraseptagenarian elderly
305
Cardiovascular Aging: What We Can Learn From Caloric Restriction
306
Cardiovascular and Antioxidant Effects of the Methanol Extract From the Stem Bark of Erythrina Senegalensis DC (Fabaceae)
307
Cardiovascular and autonomic nervous functions during acclimatization to hypoxia in conscious rats
308
Cardiovascular and behavioural components of conditioned fear to context after ganglionic and α-adrenergic blockade
309
Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)
310
Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment
311
Cardiovascular and endocrine responses to cutaneous electrical stimulation after fentanyl in the ovine fetus
312
Cardiovascular and metabolic effects of the vasopeptidase inhibitor, omapatrilat in spontaneously hypertensive rats
313
Cardiovascular and metabolic responses to two receptor-selective opioid agonists in pregnant sheep
314
Cardiovascular and Metabolic Risk Factors: How Can We Improve Outcomes in the High-Risk Patient?
315
Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68–102: The cardiovascular Health Study
316
Cardiovascular and muscle activity during chewing in whiplash-associated disorders (WAD)
317
Cardiovascular and psychosomatic symptoms among relatives of patients waiting for possible coronary revascularization
318
Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review
319
Cardiovascular and renal disease in the adolescent guinea pig after chronic placental insufficiency
320
Cardiovascular and renal effects of a collagen cross-link breaker (ALT 711) in adult and aged spontaneously hypertensive rats
321
Cardiovascular and Renal Effects of Hibiscus Sabdariffa Linnaeus. in Patients with Diabetic Nephropathy: A Randomized, Double-Blind, Controlled Trial
322
Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension
323
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture
324
Cardiovascular and Respiratory Effects of Romifidine and/or Xylazine in Ketamine Anaesthesia in Dog: An Experimental Study
325
Cardiovascular and respiratory emergency dispatch due to shortterm exposure to ambient PM10 in Dezful, Iran
326
Cardiovascular and respiratory response to ascent of the Damavand summit by classic method in elite climbers
327
Cardiovascular and Systemic MicrovascularEffects of Anti-Vascular Endothelial Growth Factor Therapy for Cancer
328
Cardiovascular and ventilatory control during exercise in chronic heart failure: Role of muscle reflexes
329
Cardiovascular anomalies associated with chromosome 22q11.2 deletion
330
Cardiovascular Anomalies Associated With Chromosome 22q11.2 Deletion Syndrome
331
Cardiovascular anomalies in patients with chromosome 22q11.2 deletion: A Korean multicenter study
332
Cardiovascular applications for artifical structural proteins produced by recombinant technologies
333
Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS
334
Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease
335
Cardiovascular autonomic function in healthy adolescents
336
Cardiovascular autonomic function testing in asymptomatic T. cruzi carriers: a sensitive method to identify subclinical Chagasʹ disease
337
Cardiovascular autonomic function tests in type 2 diabetes mellitus with micro albuminuria
338
Cardiovascular autonomic modulation by nitric oxide synthases accounts for the augmented enalapril-evoked hypotension in ethanol-fed female rats
339
Cardiovascular autonomic nervous response to postural change in 610 healthy Japanese subjects in relation to age
340
Cardiovascular autonomic neuropathy in rheumatoid arthritis assessed by cardiovascular autonomic function tests: A cross-sectional survey
341
Cardiovascular autonomic regulation in Non-Obese Diabetic (NOD) mice
342
Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes
343
Cardiovascular benefits of nuts
344
Cardiovascular Care Facts: A Report From the National Cardiovascular Data Registry: 2011
345
Cardiovascular cavitation
346
Cardiovascular changes during induced emotion: An application of langʹs theory of emotional imagery
347
Cardiovascular changes in response to ovarian stimulation
348
Cardiovascular Characteristics in American Youth With Prehypertension
349
Cardiovascular characterization of Pkd2+/LacZ mice, an animal model for the autosomal dominant polycystic kidney disease type 2 (ADPKD2)
350
Cardiovascular complications and acute ischemic stroke after the treatment with epinephrine in an anaphylactic patient
351
Cardiovascular Complications in Infants of Diabetic Mothers: An Observational Study in a Pediatric Cardiology Clinic in Tehran
352
Cardiovascular Complications in Obstructive Sleep Apnea Syndrome
353
Cardiovascular complications in patients with megaesophagus due to Chagas disease undergoing the Serra-Dَria operation
354
Cardiovascular Complications of Cancer Therapy: Incidence, Pathogenesis, Diagnosis, and Management
355
Cardiovascular Complications of Chronic Opium Consumption: A Narrative Review Article
356
Cardiovascular Complications of COVID-19 in Patients With Multiple Sclerosis: A Lesson From Our Experience
357
Cardiovascular Complications of Direct Laryngoscopy vs Video Laryngoscopy in Patients over 65 Years Old
358
Cardiovascular complications of malignant carcinoid disease, ,
359
Cardiovascular Complications of Radiotherapy
360
Cardiovascular Complications of the Guillain-Barré Syndrome
361
Cardiovascular Conditions in Patients With Aluminum Phosphide Poisoning
362
Cardiovascular consequences of laparoscopic surgery
363
Cardiovascular consequences of sleep apnea: I -Epidemiology
364
Cardiovascular consequences of sleep apnea: II-Cardiovascular mechanisms
365
Cardiovascular consequences of sleep apnea: III-Impact of continuous positive airway pressure treatment
366
Cardiovascular Considerations in Antidepressant Therapy: An Evidence-Based Review
367
Cardiovascular control and plasma catecholamines during rest and mental stress: effects of posture
368
Cardiovascular control in Antarctic fish
369
Cardiovascular data on sildenafil citrate: Introduction
370
Cardiovascular Death and Cancer Death—Competing Risk?
371
Cardiovascular death from panic disorder and panic-like anxiety: A critical review of the literature
372
Cardiovascular determinants of plasma fibronectin in an elderly population: The EVA study
373
Cardiovascular disease
374
Cardiovascular Disease Among International Travellers
375
Cardiovascular disease among Mexican Americans
376
Cardiovascular disease and bone
377
Cardiovascular disease and chronic kidney disease: Insights and an update
378
Cardiovascular disease and cognitive performance in middle-aged and elderly men
379
Cardiovascular disease and mortality in statin-treated patients with familial hypercholesterolemia
380
Cardiovascular disease and neoplasms after pancreas transplantation
381
Cardiovascular disease and neoplasms after pancreas transplantation
382
Cardiovascular disease and neoplasms after pancreas transplantation
383
Cardiovascular Disease and Olympic Games in China
384
Cardiovascular disease and risk factors among 345 adults in rural India—the Andhra Pradesh Rural Health Initiative
385
Cardiovascular disease and risk factors in adults with hypopituitarism
386
Cardiovascular disease and risk factors in Montana American Indians and non-Indians Original Research Article
387
Cardiovascular disease and risk factors in patients with type 2 diabetes mellitus in Mashhad, Islamic Republic of Iran
388
Cardiovascular Disease and Risk in Primary Care Settings in the United States
389
Cardiovascular disease and sexual functioning
390
Cardiovascular disease and sleep-related erections
391
Cardiovascular disease and the global tobacco epidemic: a wake-up call for cardiologists
392
Cardiovascular disease burden shifts
393
Cardiovascular disease detection using bio-sensing techniques
394
Cardiovascular disease events and its predictors in women: Isfahan Cohort Study (ICS)
395
Cardiovascular Disease in Adult and Pediatric HIV/AIDS
396
Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan
397
Cardiovascular Disease in Asian Americans: Unmasking Heterogeneity
398
Cardiovascular disease in Chinese type 2 diabetic women is associated with a prolonged QTc interval
399
Cardiovascular Disease in Chronic Renal Failure Patients
400
Cardiovascular disease in familial hypercholesterolaemia: Influence of low-density lipoprotein receptor mutation type and classic risk factors
401
Cardiovascular disease in Hajj pilgrims
402
Cardiovascular disease in HIV infection
403
Cardiovascular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention
404
Cardiovascular disease in Latin America
405
Cardiovascular disease in lupus patients: Should all patients be treated with statins and aspirin?
406
Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria Original Research Article
407
Cardiovascular disease in older people
408
Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan Canada: Cardiovascular Disease in COPD Patients
409
Cardiovascular disease in patients with chronic renal failure
410
Cardiovascular disease in patients with end-stage renal disease on hemodialysis in a developing country
411
Cardiovascular disease in persons with depressive and anxiety disorders
412
Cardiovascular disease in postmenopausal women: myths and reality
413
Cardiovascular disease in rheumatoid arthritis
414
Cardiovascular disease in South Asians
415
Cardiovascular disease in South Asians
416
Cardiovascular Disease in the Developing World: Prevalences, Patterns, and the Potential of Early Disease Detection
417
Cardiovascular disease in the NHANES III
418
Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives
419
Cardiovascular disease in the tropics, ethics, and need for action
420
Cardiovascular Disease Knowledge among Cardiac Rehabilitation Patients in Eastern Iran: A Cross-Sectional Study
421
Cardiovascular disease knowledge among culturally Deaf patients in Chicago
422
Cardiovascular Disease Mortality and Years of Life Lost Attributable to Non-optimal Systolic Blood Pressure and Hypertension in Northeastern Iran
423
Cardiovascular Disease Mortality in Asian Americans
424
Cardiovascular Disease Mortality in Hispanics and Non-Hispanic Whites
425
Cardiovascular Disease Patient's Quality of Life in Tabriz City in Iran in 2018
426
Cardiovascular Disease Prevention among Youth: Visioning the Future
427
Cardiovascular Disease Prevention for Women Attending Breast and Cervical Cancer Screening Programs: The WISEWOMAN Projects
428
Cardiovascular Disease Prevention in Eastern Europe
429
Cardiovascular disease prevention in Russia: Challenges and opportunities
430
Cardiovascular Disease Prevention Research at the National Heart, Lung, and Blood Institute
431
Cardiovascular Disease Prevention Using Fixed Dose Pharmacotherapy in Iran: Updated Meta-Analyses and Mortality Estimation
432
Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis
433
Cardiovascular Disease Risk Assessment: Triglyceride/High-Density Lipoprotein versus Metabolic Syndrome Criteria
434
Cardiovascular Disease Risk Factor Intervention in Low-Income Women: The North Carolina WISEWOMAN Project
435
Cardiovascular Disease Risk Factors
436
Cardiovascular Disease Risk Factors among Migrant Seasonal Agricultural Workers: Comparison with Local Residents
437
Cardiovascular Disease Risk Factors and Cardiac Markers among Male Cement Workers in Calabar, Nigeria
438
Cardiovascular Disease Risk Factors and Cognitive Impairment
439
Cardiovascular disease risk factors in 2 distinct ethnic groups: Indian and Pakistani compared with American premenopausal women
440
Cardiovascular disease risk factors in 6–7-year-old Danish children: the Copenhagen School Child Intervention Study
441
Cardiovascular Disease risk Factors in Male Cigarette Smokers in Calabar, Southern Nigeria
442
Cardiovascular Disease Risk Factors in Patients with Confirmed Cardiovascular Disease
443
Cardiovascular Disease Risk Factors Profile in Individuals With Diabetes Compared With Non-Diabetic Subjects in North-East of Iran
444
Cardiovascular disease risk factors, metabolic syndrome and obesity in an Iranian population
445
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
446
Cardiovascular disease risk prediction among Iranian patients with diabetes mellitus in Isfahan Province, Iran, in 2014, by using Framingham risk score, atherosclerotic cardiovascular disease risk score, and high-sensitive C-reactive protein
447
Cardiovascular disease risk profile among young Saudi women of Al-Qassim, Saudi Arabia: A cross-sectional study
448
Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System Original Research Article
449
Cardiovascular Disease Risk Stratification With Stress Single-Photon Emission Computed Tomography Technetium-99m Tetrofosmin Imaging in Patients With the Metabolic Syndrome and Diabetes Mellitus
450
Cardiovascular disease risks in adolescent males
451
Cardiovascular disease, chronopharmacotherapy, and the molecular clock
452
Cardiovascular disease, fibrinogen and the acute phase response: Associations with lipids and blood pressure in patients with chronic renal disease Original Research Article
453
Cardiovascular disease—risk benefits of clean fuel technology and policy: A statistical analysis
454
Cardiovascular diseases (CVD) risk factors, physical activity (PA) and plasma plasminogen (Plg) in a random sample of community-dwelling elderly
455
Cardiovascular Diseases and Risk Factors in Finland
456
Cardiovascular Diseases before and after Renal Transplantation
457
Cardiovascular diseases do not influence the mental health outcome of older men with depression over 6 years
458
Cardiovascular diseases in Latin America and the Caribbean
459
Cardiovascular Diseases in Natural Disasters; a Systematic Review
460
Cardiovascular diseases in the mirror of science
461
Cardiovascular diseases, health status, brain imaging findings and neuropsychological functioning in neurologically healthy elderly individuals
462
Cardiovascular Disorders in the Context of Non-Alcoholic Fatty Liver Disease: A Literature Review
463
Cardiovascular Disorders Risk Factors in Different Industries of Iran
464
Cardiovascular distribution of the calcium sensing receptor before and after burns
465
Cardiovascular Disturbances in Workers Exposed to Carbon Disulfide
466
Cardiovascular drug delivery with ultrasound and microbubbles
467
Cardiovascular Drug Interactions of Diclofenac and Dobutamine
468
Cardiovascular Dual Source Computed Tomography for Aortic Coarctation in a Neonate: One-Second Scan With Ultra-Low Radiation Dose
469
Cardiovascular dynamics and dimensions after bicaval and standard cardiac transplantation
470
Cardiovascular dysautonomia in Parkinsonʹs disease with visual hallucinations
471
Cardiovascular Effect of Bans on Smoking in Public Places
472
Cardiovascular Effect of Bans on Smoking in Public Places: A Systematic Review and Meta-Analysis
473
Cardiovascular Effect of Cuneiform Nucleus During Hemorrhagic Hypotension
474
Cardiovascular Effect of Dorsal Periaqueductal Gray During Lipopolysaccharide-induced Hypotension
475
Cardiovascular effect of preeclampsia upon offspring development: Are (Pro) renin-renin receptor ((P)RR) and gender related?
476
Cardiovascular effects of 6 months of hormone replacement therapy versus placebo: differences associated with years since menopause
477
Cardiovascular Effects of a Trandolapril/Verapamil Combination in Patients With Mild to Moderate Essential Hypertension
478
Cardiovascular effects of a μ-selective opioid agonist (tyrosine-D-arginine-phenylalanine-lysine-NH2) in fetal sheep: Sites and mechanisms of action, ,
479
Cardiovascular Effects of Acute Organophosphate Poisoning
480
Cardiovascular effects of Adonis aestivalis in anesthetized sheep
481
Cardiovascular Effects of Aldosterone and Post–Acute Myocardial Infarction Pathophysiology
482
Cardiovascular Effects of Allium Sativum (Garlic): An Evidence-Based Review
483
Cardiovascular Effects of Androgenic Anabolic Steroids in Male Bodybuilders Determined by Tissue Doppler Imaging
484
Cardiovascular Effects of Antidepressants and Mood Stabilizers
485
Cardiovascular effects of breast cancer radiotherapy
486
Cardiovascular effects of caffeine in men and women
487
Cardiovascular Effects of Carbamazepine Toxicity, ,
488
Cardiovascular effects of carbon monoxide and cigarette smoking
489
Cardiovascular Effects of Carbon Monoxide Poisoning
490
Cardiovascular effects of centrally applied endothelin-11–31 and its relationship to endothelin-11–21 in rats
491
Cardiovascular Effects of Circular Training (Resistance-Interval) Combined with Berberine on Overweight Elderly Men
492
Cardiovascular effects of Danshen
493
Cardiovascular effects of estrogen
494
Cardiovascular Effects of Exercise: Role of Endothelial Shear Stress
495
Cardiovascular effects of fingolimod: A review article.
496
Cardiovascular effects of French horn playing
497
Cardiovascular Effects of Hyperhomocysteinemia in Conscious Unrestrained Rats
498
Cardiovascular effects of induced hypothermia after lung transplantation
499
Cardiovascular effects of inhaled nitric oxide in a canine model of cardiomyopathy
500
Cardiovascular effects of inhaled nitric oxide in a canine model of cardiomyopathy
501
Cardiovascular effects of intravaginal misoprostol in the mid trimester of pregnancy
502
Cardiovascular effects of milk enriched with ω-3 polyunsaturated fatty acids, oleic acid, folic acid, and vitamins E and B6 in volunteers with mild hyperlipidemia
503
Cardiovascular Effects of Mixed Amphetamine Salts Extended Release in the Treatment of School-Aged Children with Attention-Deficit/Hyperactivity Disorder
504
Cardiovascular effects of nitrergic system of the pedunculopon-tine tegmental nucleus in anesthetized rats
505
Cardiovascular Effects of Olive, a Qur’anic Fruit: a Systematic Review
506
Cardiovascular effects of prolonged milrinone inhalation inpatients with pulmonary hypertension undergoing mitral valvereplacement
507
Cardiovascular effects of propranolol in normal and stressed female and male rats assessed by traditional and nonlinear dynamics methods
508
Cardiovascular effects of raloxifene: the arterial and venous systems
509
Cardiovascular Effects of Saffron: An Evidence-Based Review
510
Cardiovascular effects of sex hormones
511
Cardiovascular effects of sildenafil citrate and recommendations for its use
512
Cardiovascular effects of standardized hydroalcoholic extract of Ribes khorasanicum fruit in acute hypertensive rats
513
Cardiovascular effects of systemic cancer treatment
514
Cardiovascular effects of tadalafil
515
Cardiovascular effects of tadalafil in patients on common antihypertensive therapies
516
Cardiovascular effects of transdermal nicotine in mildly hypertensive smokers
517
Cardiovascular effects of two amides (Piperine and Piperdardine) isolated from Piper tuberculatum Jacq.
518
Cardiovascular Emergencies in Cruise Ship Passengers
519
Cardiovascular endocrinology springs surprises
520
Cardiovascular Event Rates in Diabetic and Nondiabetic Individuals With and Without Established Atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)
521
Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol <50 mg/dl With Rosuvastatin: The JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvast
522
Cardiovascular event risk in relation to arterial stiffness in patients with subclinical peripheral atherosclerosis
523
Cardiovascular Event Risk: High-Density Lipoprotein and Paraoxonase
524
Cardiovascular Events and Football Tournaments
525
Cardiovascular Events and Mortality in Newly and Chronically Depressed Persons >70 Years of Age
526
Cardiovascular events and plasma atrial natriuretic peptide level in patients with hypertrophic cardiomyopathy
527
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial
528
Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes
529
Cardiovascular events during initial antihypertensive therapy with either a calcium antagonist or a diuretic/beta-blocker: meta-analysis of 7 clinical trials
530
Cardiovascular Events in Patients With Coronary Plaque Rupture and Nonsignificant Stenosis
531
Cardiovascular Events in Patients With Fabry Disease: Natural History Data From the Fabry Registry
532
Cardiovascular Events in People With Type 2 Diabetes: Performance of Framingham, UKPDS, and ADVANCE Risk Equations
533
Cardiovascular Events in the 1996 Olympic Games
534
Cardiovascular Factors and Cognitive Impairment: A Role for Unsaturated Fatty Acids and Mediterranean Diet?
535
Cardiovascular Features of Heart Failure With Preserved Ejection Fraction Versus Nonfailing Hypertensive Left Ventricular Hypertrophy in the Urban Baltimore Community: The Role of Atrial Remodeling/Dysfunction Original Research Article
536
Cardiovascular findings in patients with psoriasis.
537
Cardiovascular fitness and neurocognitive function in older Adults: a brief review
538
Cardiovascular Function and Predictors of Exercise Capacity in Patients With Colorectal Cancer
539
Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice
540
Cardiovascular gene delivery: The good road is awaiting
541
Cardiovascular gene therapy Review Article
542
Cardiovascular Gene Therapy: Advances and Challenges
543
Cardiovascular Genetics, Genomics, and Proteomics
544
Cardiovascular genomics
545
Cardiovascular Genomics: Estimating the Total Number of Genes Expressed in the Human Cardiovascular System
546
Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study
547
Cardiovascular Health among Adults in Syria: A Model from Developing Countries
548
Cardiovascular health and economic effects of smoke-free workplaces
549
Cardiovascular health and economic effects of smoke-free workplaces: Am J Med. 2004;117:32-38
550
Cardiovascular Health Awareness Program (CHAP): A community cluster-randomised trial among elderly Canadians
551
CARDIOVASCULAR HEALTH EDUCATION OF FAMILIES: THE IMPORTANCE OF SCHOOL-BASED PREVENTION STRATEGIES
552
Cardiovascular Health in Europe: A Global Problem
553
Cardiovascular Health in Men Attending for Abdominal Aortic Aneurysm Screening
554
Cardiovascular hybrid drugs: new benzazepinone derivatives as bradycardic agents endowed with selective β1-Non-competitive antagonism Original Research Article
555
Cardiovascular imaging
556
Cardiovascular Imaging in Thalassemia: An Issue With Limited Data
557
Cardiovascular Imaging in the Management of Atrial Fibrillation Review Article
558
Cardiovascular implications of the factor V Leiden mutation
559
Cardiovascular Interventions in Clinical Practice
560
Cardiovascular Inventiveness Within the University of Minnesota Department of Surgery
561
cardiovascular involvement in blood cancers: all, aml, cll, and cml
562
Cardiovascular Involvement in Children with Osteogenesis Imperfecta
563
Cardiovascular involvement in patients with systemic sclerosis: insights from electromechanical characteristics of the heart
564
Cardiovascular involvement in systemic autoimmune diseases
565
Cardiovascular Issues in Hypogonadism and Testosterone Therapy
566
Cardiovascular Magnetic Resonance Determinants of Left Ventricular Noncompaction
567
Cardiovascular magnetic resonance findings in typical versus atypical forms of the acute apical ballooning syndrome (Takotsubo cardiomyopathy)
568
Cardiovascular Magnetic Resonance for Risk Stratification of Arrhythmia in Hypertrophic Cardiomyopathy
569
Cardiovascular magnetic resonance for the assessment of pulmonary arterial hypertension: toward a comprehensive CMR exam
570
Cardiovascular Magnetic Resonance for the Diagnosis of Acute Myocarditis: Prospects for Detecting Myocardial Inflammation
571
Cardiovascular magnetic resonance imaging demonstrates mitral valve endocarditis
572
Cardiovascular magnetic resonance imaging: Current and emerging applications Review Article
573
Cardiovascular Magnetic Resonance in Arrhythmogenic Right Ventricular Cardiomyopathy Revisited: Comparison With Task Force Criteria and Genotype Original Research Article
574
Cardiovascular Magnetic Resonance in Clinically Suspected Cardiac Amyloidosis: Diagnostic Value of a Typical Pattern of Late Gadolinium Enhancement
575
Cardiovascular Magnetic Resonance in Clinically Suspected Cardiac Amyloidosis: Noninvasive Imaging Compared to Endomyocardial Biopsy Original Research Article
576
Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
577
Cardiovascular Magnetic Resonance in Patients With Myocardial Infarction: Current and Emerging Applications
578
Cardiovascular Magnetic Resonance in Predicting the Reduction in Pulmonary Artery Pressure in Patients With Mitral Stenosis After Surgical or Interventional Treatment
579
Cardiovascular magnetic resonance in the follow-up of patients with corrected tetralogy of Fallot: A review
580
Cardiovascular magnetic resonance of asymptomatic myocardial infarction
581
Cardiovascular magnetic resonance of iatrogenic ventricular scarring due to catheter ablation for left ventricular tachycardia
582
Cardiovascular Magnetic Resonance of imminent cardiac tamponade due to postpericardiotomy syndrome
583
Cardiovascular magnetic resonance ofacute myocardial infarction at a very early stage
584
Cardiovascular Magnetic Resonance Perfusion Imaging at 3-Tesla for the Detection of Coronary Artery Disease: A Comparison With 1.5-Tesla Original Research Article
585
Cardiovascular magnetic resonance signs of ischemia in hypertrophic cardiomyopathy
586
Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy Original Research Article
587
Cardiovascular Magnetic Resonance: Warren J. Manning and Dudley J. Pennell, London, UK, Churchill Livingstone 2002, 506 pages, 367 illustrations, US$120.00
588
Cardiovascular Malformations in Congenital Rubella Syndrome: A Case Report
589
Cardiovascular malformations in Fryns Syndrome
590
Cardiovascular Malformations in Infants of Diabetic Mothers: A Retrospective Case-Control Study
591
Cardiovascular Manifestation of a Family with Marfan’s Syndrome
592
Cardiovascular manifestations associated with influenza virus infection
593
Cardiovascular manifestations in COVID-19 patients: A systematic review and meta-analysis
594
Cardiovascular Manifestations in Human Immunodeficiency Virus-Infected Patients
595
Cardiovascular manifestations of anabolic steroids in association with demographic variables in body building athletes
596
Cardiovascular Manifestations of Carbon Monoxide Poisoning
597
Cardiovascular Manifestations of Hyperthyroidism Before and After Antithyroid Therapy: A Matched Case-Control Study Original Research Article
598
Cardiovascular Manifestations of Moderate to Severe Carbon Monoxide Poisoning Original Research Article
599
Cardiovascular manifestations of pheochromocytoma
600
Cardiovascular Medications and Risk of Cancer
601
Cardiovascular medicine update
602
Cardiovascular monitoring advised during growth hormone therapy
603
Cardiovascular Morbidity and Mortality in Community-Dwelling Elderly Individuals With Calcification of the Fibrous Skeleton of the Base of the Heart and Aortosclerosis (The Cardiovascular Health Study)
604
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End point reduction in hypertension (LIFE) study Original Research Article
605
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
606
Cardiovascular Morbidity and Mortality in Rheumatoid Arthritis
607
Cardiovascular Morbidity and Mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in Chronic Renal Failure: A Multicenter, Randomized, Controlled Trial Original Research Article
608
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
609
Cardiovascular Morphing
610
Cardiovascular Mortality and Heart Failure Risk Score for Patients After ST-Segment Elevation Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (Data from the Leiden MISSION! Infarct Registry)
611
Cardiovascular mortality focusing on socio-economic influence: The low-risk population of Halland compared to the population of Sweden as a whole
612
Cardiovascular Mortality in Chronic Kidney Disease Patients Undergoing Percutaneous Coronary Intervention Is Mainly Related to Impaired P2Y12 Inhibition by Clopidogrel
613
Cardiovascular Mortality in High-Risk Patients and T-786C Polymorphism in Promoter Region of the Endothelial Nitric Oxide Synthase Gene
614
Cardiovascular mortality in New York City after September 11, 2001
615
Cardiovascular mortality in patients followed up for diabetic foot
616
Cardiovascular Mortality of Turkish Nationals Residing in West Germany
617
Cardiovascular neurons of the rat brain express extracellular calcium-sensing receptors
618
Cardiovascular operations in patients with dialysis-dependent renal failure
619
Cardiovascular outcome in hospitalized patients with minimal troponin I elevation and normal creatine phosphokinase
620
Cardiovascular Outcome in Relation to Progression to Hypertension in the Copenhagen MONICA Cohort
621
Cardiovascular Outcome in Treated Hypertensive Patients with Responder, Masked, False Resistant, and True Resistant Hypertension
622
Cardiovascular outcome of patients with abnormal coronary vasomotion and normal coronary arteriography is worse in type 2 diabetes mellitus than in arterial hypertension: A 10 year follow-up study
623
Cardiovascular Outcomes in Male Veterans With Rheumatoid Arthritis
624
Cardiovascular Outcomes in Randomized Trials: Should Time to First Event for “Hard” End Points Remain the Standard Approach?
625
Cardiovascular Outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management): An Assessment of Individual Antiarrhythmic Drug Therapies Compared With Rate Control With Propensity Score-Matched Analyses
626
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison
627
Cardiovascular Pathology A platform for research, teaching, and clinical care
628
Cardiovascular pathology at the crossroads: the dilemma of cardiac pathologists
629
Cardiovascular pathology in the land of doges
630
Cardiovascular Pathology: a new journal for an old need
631
Cardiovascular pathology: Clinicopathological correlations and pathogenetic mechanisms : Schoen FJ, Gimbrone MA (editors) Williams and Wilkins, Georgia, USA; 229 pp.; £67.00; ISBN 0-683-07600-0
632
Cardiovascular Pathology: From whence we came … to where we are going
633
Cardiovascular pathology: maturation of a discipline and the Society for Cardiovascular Pathology
634
Cardiovascular patients’ experiences of living with pacemaker: Qualitative study
635
Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerations
636
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction
637
Cardiovascular Phenotype in HFpEF Patients With or Without Diabetes: A RELAX Trial Ancillary Study
638
Cardiovascular Preventing Effects of Dipeptidyl Peptidase-4 Inhibitors: Beyond Glucagon-Like Peptide-1
639
Cardiovascular Prevention in Asymptomatic Diabetic Patients
640
Cardiovascular Prevention in Diabetes Mellitus: No Magic Remedies
641
Cardiovascular prevention in the Hartslag Limburg project: Effects of a high-risk approach on behavioral risk factors in a general practice population
642
Cardiovascular professionalism and ethics in the modern era Review Article
643
Cardiovascular profile of loratadine
644
Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: Results from the Angina Prognosis Study in Stockholm (APSIS) Original Research Article
645
Cardiovascular prognostic value of vascular involvement in Behcetʹs disease
646
Cardiovascular Property of Resistance Training With an Emphasis on PI3K/AKT1 Genes Expression in Type 2 Diabetic Rats
647
Cardiovascular protection and blood pressure reduction: a meta-analysis
648
Cardiovascular protection in haemophilia
649
Cardiovascular protection of deep-seawater drinking water in high-fat/cholesterol fed hamsters
650
Cardiovascular protection of nonmitogenic human acidic fibroblast growth factor from oxidative damage in vitro and in vivo
651
Cardiovascular Protection Using Beta-Blockers: A Critical Review of the Evidence Review Article
652
Cardiovascular protective effect of darbepoetin-α: A long-acting erythropoietic analogue
653
Cardiovascular proteomic analysis
654
Cardiovascular Proteomics: Tools to Develop Novel Biomarkers and Potential Applications Review Article
655
Cardiovascular reactivity and hostility: The dynamic cerebral laterality effect
656
Cardiovascular reactivity, affective responses and performance related to the risk dimensions of coronary-prone behaviour
657
Cardiovascular recovery from laboratory stress: Biopsychosocial concomitants in older adults
658
Cardiovascular regulation by -atginine in the brain of rats : Role of the brain renin-angiotensin system and nitric oxide
659
CARDIOVASCULAR REGULATION IN TGR(mREN2)27 RATS: 24h VARIATION IN PLASMA CATECHOLAMINES, ANGIOTENSIN PEPTIDES, AND TELEMETRIC HEART RATE VARIABILITY
660
Cardiovascular remodeling after AVF surgery in rats assessed by a clinical MRI scanner
661
Cardiovascular remodeling and arterial hypertension in rheumatoid arthritis: Predisposing conditions and risk factors  
662
Cardiovascular remodeling is greater in isolated systolic hypertension than in diastolic hypertension in older adults: the Insufficienza Cardiaca negli Anziani Residenti (ICARE) a Dicomano Study
663
Cardiovascular remodeling, apoptosis, and drugs
664
Cardiovascular research in Spain. A comparative scientometric study
665
Cardiovascular response to sexual activity
666
Cardiovascular responses across stressor phases: The match of gender and gender-role identification with the gender relevance of the stressor
667
Cardiovascular Responses during Head-Down Crooked Kneeling Position Assumed in Muslim Prayers
668
Cardiovascular responses evoked by mild cool stimuli in primary Raynauds disease: the role of endothelin
669
Cardiovascular responses in humans to experimental chewing of gums of different consistencies
670
Cardiovascular responses in patients with acute allergic reactions treated with parenteral epinephrine
671
Cardiovascular responses induced by Catalase Inhibitior into the Fourth Cerebral Ventricle is changed in Wistar rats exposed to sidestream cigarette smoke
672
Cardiovascular responses of perimenopausal women to hormonal replacement therapy, ,
673
Cardiovascular responses of physically active colligate subjects during normal and warm conditions, and determination of sweat rates
674
Cardiovascular responses produced by resistin injected into paraventricular nucleus mediated by the glutamatergic and CRFergic transmissions within rostral ventrolateral medulla
675
Cardiovascular responses to agency and communion stressors in young women
676
Cardiovascular responses to aquatic walking in middle-aged and elderly persons with physical disabilities
677
Cardiovascular responses to chemoreflex activation with potassium cyanide or hypoxic hypoxia in awake rats
678
Cardiovascular responses to clonidine in alcohol withdrawal: are they related to psychopathology and mental well-being?
679
Cardiovascular responses to dynamic submaximal exercise in children previously treated with anthracycline
680
Cardiovascular responses to electrical stimulation of sympathetic nerves in the pithed mouse
681
Cardiovascular responses to exercise in children and adolescents with myocardial dysfunction
682
Cardiovascular responses to laughter: A pilot project
683
Cardiovascular responses to microinjection of AMPA into the rostral commissural nucleus tractus solitarius of awake rats
684
CARDIOVASCULAR RESPONSES TO OROTRACHEAL INTUBATION IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING SURGERY (Comparing Fiberoptic Bronchoscopy With Direct Laryngoscopy)
685
CARDIOVASCULAR RESPONSES TO SCALP INFILTRATION, USING ADRENALINE, WITH OR WITHOUT LIGNOCAINE, DURING CRANIOTOMY
686
Cardiovascular responses to sciatic nerve stimulation are blocked by paratrigeminal nucleus lesion
687
Cardiovascular responses to the injection of L-glutamate in the lateral hypothalamus of unanesthetized or anesthetized rats
688
Cardiovascular Responses to Tonic Pain in REM Sleep-Deprived Rats Role of Melatonin and Beta Endorphin
689
Cardiovascular Risk After Bariatric Surgery for Obesity
690
Cardiovascular Risk Among Adults With Chronic Kidney Disease, With or Without Prior Myocardial Infarction Original Research Article
691
Cardiovascular Risk Among Men Seeking Help for Erectile Dysfunction
692
Cardiovascular risk and atherosclerosis prevention
693
Cardiovascular risk and blood pressure reduction: an overview of the outcome trials
694
Cardiovascular risk and sildenafil
695
Cardiovascular risk assessment
696
Cardiovascular risk assessment
697
Cardiovascular risk assessment in HIV-infected patients attending a designated lipid clinic
698
Cardiovascular Risk Assessment of Liver Transplantation Candidates
699
Cardiovascular Risk Assessment of Pulmonary Embolism With the GRACE Risk Score
700
Cardiovascular Risk Assessment of the Liver Transplant Candidate
701
Cardiovascular risk associated with hormone replacement therapy: some critical questions about the type of estrogen used in most clinical trials
702
Cardiovascular risk changes after lipid lowering medications: are they predictable?
703
Cardiovascular risk continuum: implications of insulin resistance and diabetes
704
Cardiovascular Risk Estimation and Eligibility for Statins in Primary Prevention Comparing Different Strategies
705
Cardiovascular Risk Factor Control and Adherence to Recommended Lifestyle and Medical Therapies in Persons With Coronary Heart Disease (from the National Health and Nutrition Examination Survey 2007–2010)
706
Cardiovascular risk factor profiles and their social gradient from adolescence to age 74 in a Swiss region
707
Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial
708
Cardiovascular Risk Factors among Children after a 2image-Year Intervention—The CATCH Study
709
Cardiovascular risk factors among retired attendees visiting primary care clinics
710
Cardiovascular Risk Factors and Acculturation in Yaquis and Tepehuanos Indians from Mexico
711
Cardiovascular risk factors and alcohol consumption in France and Northern Ireland Original Research Article
712
Cardiovascular Risk Factors and Confounders Among Nondrinking and Moderate-Drinking U.S. Adults
713
Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults
714
Cardiovascular Risk Factors and Coronary Atherosclerosis in Retired National Football League Players
715
Cardiovascular Risk Factors and COVID-19 incidence- Result from a population based study
716
Cardiovascular risk factors and hyperinsulinemia in elderly men: The Honolulu Heart Program
717
CARDIOVASCULAR RISK FACTORS an‎d IN-HOSPITAL MORTALITY IN 1258 CASES OF CORONARY ARTERY BYPASS SURGERY IN TEHRAN HEART CENTER
718
Cardiovascular risk factors and migraine without aura: A case-control study.
719
Cardiovascular Risk Factors and Nutritional Intake are not Associated with Ultrasound-defi ned Increased Carotid Intima Media Thickness in Individuals Without a History of Cardiovascular Events
720
Cardiovascular Risk Factors and Specific Coronary Artery Calcification in Postmenopausal Women
721
Cardiovascular Risk Factors Are on the Rise in Developing Countries
722
Cardiovascular risk factors are really linked in the metabolic syndrome: This phenomenon suggests clustering rather than coincidence
723
Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population
724
Cardiovascular risk factors associated with enlarged diameter of the abdominal aortic and iliac arteries in healthy women
725
Cardiovascular risk factors associated with migraine
726
Cardiovascular Risk Factors Clustering Features of Insulin Resistance Syndrome (Syndrome X) in a Biracial (Black-White) Population of Children, Adolescents, and Young Adults The Bogalusa Heart Study
727
Cardiovascular Risk Factors Clustering Features of Insulin Resistance Syndrome (Syndrome X) in a Biracial (Black-White) Population of Children, Adolescents, and Young Adults The Bogalusa Heart Study
728
Cardiovascular Risk Factors Determine Erectile and Arterial Function Response to Sildenafil
729
Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction
730
Cardiovascular Risk Factors in Adolescence: Prevalence and Familial Aggregation
731
Cardiovascular risk factors in ethnic minority women aged ≤30 years
732
Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients
733
Cardiovascular Risk Factors in Hypertension: Rationale and Design of Studies to Investigate the Effects of Controlled-Release Carvedilol on Regression of Left Ventricular Hypertrophy and Lipid Profile
734
Cardiovascular Risk Factors in Italy
735
Cardiovascular risk factors in Kuwaiti adults with type 2 diabetes
736
Cardiovascular risk factors in Montana American Indians with and without diabetes Original Research Article
737
Cardiovascular risk factors in non-insulin-dependent diabetics compared to non-diabetic controls: a population-based survey among Asians in Singapore Original Research Article
738
Cardiovascular risk factors in patients aged 85 or older with ischemic stroke
739
Cardiovascular risk factors in people abovetwenty years old in Gonabad, Iran
740
Cardiovascular risk factors in relation to cigarette smoking: a population-based survey among Asians in Singapore Original Research Article
741
Cardiovascular risk factors in Tanzania: a revisit
742
Cardiovascular risk factors in the urban Mexican population: The FRIMEX study
743
Cardiovascular Risk Factors in Young Patients of Coronary Artery Disease: Differences over a Decade
744
Cardiovascular risk factors in youth with implications for aging: The Bogalusa Heart Study
745
Cardiovascular risk factors of hypertension, smoking and obesity: Emerging concerns among Pathan and Persian young adults?
746
Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension
747
Cardiovascular Risk Factors: A Study on the Prevalence of MS among 11-18 Years Old School Children in East of Iran, 2012
748
Cardiovascular risk in a hypertension clinic-implications of the Sheffield Table for lipid-lowering strategy
749
Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration: A Systematic Meta-Analysis
750
Cardiovascular risk in long-term survivors of testicular cancer: Vaughn DJ, Palmer SC, Carver JR, Jacobs LA, Mohler ER, Department of Medicine, Hematology/Oncology Division, University of Pennsylvania, Philadelphia, PA; Department of Psychiatry, Universit
751
Cardiovascular Risk in Men Aged Over 40 in Boa Vista, Brazil
752
Cardiovascular risk in patients with bipolar disorder
753
Cardiovascular Risk in Patients With Fasting Blood Glucose Levels Within Normal Range
754
Cardiovascular Risk in Patients With Human Immunodeficiency Virus Infection: Incomplete Data
755
Cardiovascular risk in patients with plaque psoriasis and psoriatic arthritis without a clinically overt cardiovascular disease: the role of endothelial progenitor cells
756
Cardiovascular risk in rheumatoid arthritis
757
Cardiovascular Risk in Survivors of Stroke Original Research Article
758
Cardiovascular Risk in Women With Non-Specific Chest Pain (from the Womenʹs Health Initiative Hormone Trials)
759
Cardiovascular Risk in Women With PCOS
760
Cardiovascular risk management in clinical practice: the midwest heart specialists experience
761
Cardiovascular risk models; is there an ideal model?
762
Cardiovascular risk of antidepressant use in elderly medicare beneficiaries: Comparison by therapeutic class
763
Cardiovascular Risk Perception among Iranian Women with type 2 Diabetes Mellitus
764
Cardiovascular Risk Profile and Lifestyle Habits in a Cohort of Italian Cardiologists (from the SOCRATES Survey)
765
Cardiovascular Risk Profile of Apparently Healthy Workers in a Tertiary Hospital in Nigeria
766
Cardiovascular risk profiles in UK-born Caribbeans and Irish living in England and Wales
767
Cardiovascular Risk Profiles of Oral Contraceptive Users and Nonusers: A Population-Based Study
768
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: The life study Original Research Article
769
Cardiovascular risk reductions associated with aggressive lifestyle modification and cardiac rehabilitation
770
Cardiovascular risk score in Rheumatoid Arthritis
771
Cardiovascular risk stratification by means of the SCORE system in health care workers in Veracruz, Mexico
772
Cardiovascular risk stratification of pulmonary embolism
773
Cardiovascular Risk Stratification With Plasma B-Type Natriuretic Peptide Levels in a Community-Based Hypertensive Cohort
774
Cardiovascular Risk-Factors in the Eastern Iranian Population: Are We Approaching 25×25 Target?
775
Cardiovascular risk-factors predict progression of urinary albumin-excretion in a general, non-diabetic population: A gender-specific follow-up study
776
CARDIOVASCULAR RISKS AMONG SHIFT AND NON-SHIFT WORKERS IN A PUBLIC MEDICAL CENTRE IN KUALA LUMPUR
777
Cardiovascular safety of cyclo-oxygenase-2 inhibitors
778
Cardiovascular safety of cyclo-oxygenase-2 inhibitors – Authorsʹ reply
779
Cardiovascular safety of fexofenadine HCI
780
Cardiovascular Safety of Fexofenadine HCl
781
Cardiovascular safety of maximal strength testing in healthy adults
782
Cardiovascular safety of rosiglitazone
783
Cardiovascular safety of sublingual apomorphine in patients on stable doses of oral antihypertensive agents and nitrates
784
Cardiovascular Safety Update of Tadalafil: Retrospective Analysis of Data from Placebo-Controlled and Open-Label Clinical Trials of Tadalafil With As Needed, Three Times-per-Week or Once-a-Day Dosing
785
Cardiovascular Screening and Emergency Procedures at Health Clubs and Fitness Centers
786
Cardiovascular sequelae of childhood hypertension
787
Cardiovascular solid mechanics. Cells, tissues, and organs: Jay D. Humphrey (Ed.); Springer verlag, New York, 2002, pp. 776, price US$99.00 hardback, ISBN 0-387-95168-7
788
Cardiovascular status of infants and children of women infected with HIV-1 (P2C2 HIV): a cohort study
789
Cardiovascular stent design and vessel stresses: a finite element analysis
790
Cardiovascular stents: overview, evolution, and next generation
791
Cardiovascular stress response and coronary artery disease: Evidence of an adverse postmenopausal effect in women, , , ,
792
Cardiovascular surgeonʹs remarks cause uproar in Spain
793
Cardiovascular system and intermittent stress: Bloodless adaptation to blood loss
794
Cardiovascular system is at higher risk of affecting by COVID-19
795
Cardiovascular targets for estrogens and phytoestrogens: Transcriptional regulation of nitric oxide synthase and antioxidant defense genes
796
Cardiovascular Therapies and Risk for Development of Diabetes Review Article
797
Cardiovascular therapy of neurosurgical patients
798
Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib
799
Cardiovascular tissue engineering
800
Cardiovascular Tissue Engineering Therapy: So Near, So Far?
801
Cardiovascular Toxicity of Nicotine: Implications for Nicotine Replacement Therapy
802
Cardiovascular Ultrasonographic Features and Clinical Findings for Intravenous Leiomyomatosis: A Case Report
803
Cardiovascular variability characteristics in obstructive sleep apnea
804
Cardiovascular variability during periodic leg movements: a spectral analysis approach
805
Cardiovascular, Antinociceptive and Sedative Effects of Medetomidine Infusion in Sevoflurane Anesthesia in Puppies
806
Cardiovascular, Haematological and Biochemical Responses After Large Volume Blood Collection in Horses
807
Cardiovascular, neuroendocrine, and monoaminergic responses to psychological stressors: Possible differences between remitted panic disorder patients and healthy controls
808
Cardiovascular, respiratory, and panic reactions to epinephrine in panic disorder patients
809
Cardiovascular-radical outcome method is effective in complex congenital cardiac lesions
810
Cardiovascular-Renal Responses to Long-Term Nitric Oxide Inhibition During Angiotensin II-AT1 Receptor Inhibition
811
Cardioversion for Atrial Fibrillation: Does Inflammation Matter?
812
Cardioversion of atrial fibrillation and its effect on right ventricular function as assessed by tricuspid annular motion
813
Cardioversion of atrial fibrillation in the elderly
814
Cardioversion of atrial fibrillation in the setting of mild to moderate heart failure
815
Cardioversion of atrial fibrillation to sinus rhythm: who, when, how, and why?
816
Cardioversion of Paroxysmal Atrial Fibrillation in the Emergency Department, ,
817
Cardioversion under the guidance of transesophageal echochardiograhy in persistent atrial fibrillation: results with low molecular weight heparin
818
Cardioversion With Novel Oral Anticoagulants: Reconfirming a 50-Year-Old Standard
819
Cardioverter defibrillator implantation in an adult with isolated noncompaction of the ventricular myocardium
820
Cardioverter-defibrillator implantation in the catheterization laboratory: Initial experiences in 48 patients
821
Cardioverter-defibrillator oversensing due to double counting of ventricular tachycardia electrograms
822
CardioVision 2020: Program Acceptance and Progress After 4 Years Original Research Article
823
Cardiovocal syndrome after transradial cardiac catheterization: An unusual complication
824
CardioWest Total Artificial Heart in a Moribund Adolescent With Left Ventricular Thrombi
825
CardioWest Total Artificial Heart: Bad Oeynhausen Experience
826
Cardiprotective effects of chronic hypoxia and preconditioning are not additive. Role of mitochondrial KATP channels
827
Cardo poly(arylene ether sulfone) block copolymers with pendant imidazolium side chains as novel anion exchange membranes for direct methanol alkaline fuel cell
828
Cardosin A as a model aspartic proteinase for the study of organic solvent effects: An overview on catalytic and structural aspects
829
Cardre to be absorbed into LCW after acquisition by Sensient Technologies
830
Cardré’s black iron oxide for eye make-up
831
Cardy states, factorization and idempotency in closed string field theory Original Research Article
832
Cardy–Verlinde formula and asymptotically de Sitter spaces
833
Cardy–Verlinde formula and thermodynamics of black holes in de Sitter spaces Original Research Article
834
Care after cure in leprosy
835
Care and cure. An integrated approach to psychosomatic medicine: A report from the second annual conference the EAPM, Sibiu, 2014
836
Care and despair in the UK National Health Service
837
Care and Do Not Harm: Possible Misunderstandings With Quaternary Prevention (P4); Comment on “Quaternary Prevention, an Answer of Family Doctors to Over Medicalization”
838
Care and feeding of reproducible econometrics
839
Care and NonCare‑Related Activities among Critical Care Nurses: A Cross‑Sectional Observational Time and Motion Study
840
Care and outcomes of elderly patients with acute myocardial infarction by physician specialty: the effects of comorbidity and functional limitations
841
Care and Support for Adolescents Living with HIV/AIDS in School Settings: Perspectives of Teachers and Administrators in the Southern Highlands of Tanzania
842
Care and Use of Diamond Knives
843
Care at first-level facilities for children with severe pneumonia in Bangladesh: a cohort study
844
Care Burden in Parents of Children with Leukemia: A Cross-Sectional Study in the West of Iran
845
Care concordant with guidelines predicts decreased long-term mortality in patients with unstable angina pectoris and non–ST-Elevation myocardial infarction
846
Care delivery innovation in an integrated health system
847
Care Dependency and Diabetes Self-Care Activities in Elderly Individuals with Diabetes
848
Care disparities: Moving from gray to black and white
849
Care emerges from chaos
850
Care for elderly in USA goes subacute
851
Care for Evidence-Based Applications During Pregnancy
852
Care for stroke patients
853
Care for stroke patients
854
Care for stroke patients
855
Care in comatose surviors of cardiac arrest
856
Care in the community
857
Care Instability in Nursing Homes; A Qualitative Study
858
Care Integration – From “One Size Fits All” to Person Centred Care; Comment on “Achieving Integrated Care for Older People: Shuffling the Deckchairs or Making the System Watertight for the Future?”
859
Care Management Challenges for Diabetic Foot Ulcers: A Qualitative Study
860
Care meanings, expressions, and experiences of those with chronic mental illness
861
Care needs and point prevalence of post-acute patients in the acute medical wards of an Italian hospital
862
Care needs and preferences from the perspective of COVID-19 patients: A qualitative study
863
Care Needs in the Phase I of Cardiac Rehabilitation: A Hybrid Concept Analysis
864
Care Needs of Children with Inborn Errors of Metabolism and Their Parents: An Integrative Review
865
Care Needs of Patients with Cancer; a Systematic Review
866
Care of acute myocardial infarction by nonivasive and invasive cardiologist: Procedure use, cost and outcome
867
Care of burns victims in Europe
868
Care of cardiac surgical patients
869
Care of children who have had surgery for congenital heart disease
870
CARE OF DEMENTIA IN CANADA: A COLLABORATIVE CARE APPROACH WITH A CENTRAL ROLE FOR THE PRIMARY CARE PHYSICIAN
871
Care of Diabetic Retinopathy Patients in Oman
872
Care of handicapped in Gaza
873
Care of learning-disabled Russian children condemned
874
Care of Minor Injuries by Emergence Nurse Practitioners or Junior Doctors: A Randomised Controlled Trial
875
Care of minor injuries by emergency nurse practitioners or junior doctors: a randomised controlled trial Original Research Article
876
Care of non-ST-segment elevation patients: Insights from the crusade national quality improvement initiative
877
Care of older people in nursing homes: an Intensive Programme as an educational activity within Erasmus–Socrates
878
Care of terminally-ill patients: an opinion survey among critical care healthcare providers in the Middle East
879
Care of the adult with congenital heart disease: introduction
880
Care of the Athlete With Type 1 Diabetes Mellitus: A Clinical Review
881
Care of the critically ill parturient: oliguria and renal failure
882
Care of the elderly with gastrointestinal problems in family practice
883
Care of the end-stage renal disease patient on dialysis in the ED
884
Care of the organization: Training and development strategies
885
Care of the pacemaker/implantable cardioverter defibrillator patient in the ED
886
Care of the patient close to death
887
Care of the renal transplant recipient in the emergency department
888
Care of the woman with hypertension in pregnancy: the viewpoint of the midwife
889
Care or control: health or criminal justice options for the long-term seriously mentally ill in a Canadian province
890
Care or scare: The safety of youth in congregate care in New York City
891
Care pathways for south Asian and white people with depressive and anxiety disorders in the community
892
Care pathways in thrombosis management: the INNOVATE peer-to-peer educational initiative
893
Care process and satisfaction analysis of a transmural home care program Original Research Article
894
Care Process in Iranian Nursing Homes: A Grounded Theory Study
895
Care Providers’ Perspectives on Quality Prenatal Care in High-risk Pregnancies: A Qualitative Study
896
Care provision and community adjustment of rural consumers with serious mental illness
897
Care seeking in Sri Lanka: one possible explanation for low childhood mortality
898
Care Seeking Patterns of STIs-Associated Symptoms in Iran: Findings of a Population-Based Survey
899
Care Seeking Practices of Mothers Regarding Four Key Family Practices Related to Child Health and Development
900
Care to be a nurse? Reflections on a radio broadcast and its ramifications for nursing today
901
Care Work Migration in Germany: Semi-Compliance and Complicity
902
CARE: an automobile crash data analysis tool
903
Carebene and isocyanide ligation at ruthenium(II) with (η6-arene) and tethered phosphinopropylarene ligands
904
CAREdose 4D Application in Brain CT Scan: The Effect on Dose and Image Quality
905
Career advancement and scientific performance in universities
906
Career analysis: a case study of hotel general managers in Australia
907
Career anchors and disturbances in job turnover decisions – A case study of IT professionals in Taiwan
908
Career anchors and paths: The case of Gay, Lesbian, & Bisexual workers
909
Career Aspirations And Pregnancy Intentions In Pregnant Teens
910
Career atifaction and urgical practice pattern among female ophthalmologit
911
Career choices for career growth
912
Career choices in health care: Is nursing a special case? A content analysis of survey data
913
Career concerns and mandated disclosure
914
Career concerns in a simple experimental labour market
915
CAREER CONSULTATION AS AN INTERVENTION STRATEGY IN ALLEVIATING FAMILY’S MENTAL HEALTH: A CASE STUDY ON STUDENTS WITH DISABILITIES
916
Career Counseling For Management Students
917
CAREER COUNSELLING FOR CLIENTS WITH PHYSICAL DISABILITIES IN MALAYSIAN CONTEXT
918
Career Decision-Making Self-Efficacy and Its Implications in High School Students during the Covid-19 Pandemic
919
Career decisions: The interim option
920
Career development for infection and immunity research in Uganda: a decade of experience from the Makerere University – Uganda Virus Research Institute research and training programme
921
Career development in organizations and beyond: Balancing traditional and contemporary viewpoints
922
Career development of female managers in retailing: Inhibitors and enablers
923
Career Development of Nursing Preceptors in Iran: A Descriptive Study
924
Career Development of School Psychologists
925
Career Development through E-Learning: The Importance of a Competence-Based Learning Approach
926
Career Dis-integration and Re-integration in Mergers and Acquisitions:: Managing Competence and Motivational Intangibles
927
Career Education in the Primary Grades: Building Work-Readiness Through an Experiential Curriculum
928
Career Guidance Methods for Increasing Career Maturity in Grade IX Students at SMPN 15 Yogyakarta
929
Career guidancefor student nurses: an unmet need
930
Career Indecision and Career Anxiety in High School Students: An Investigation through Structural Equation Modelling
931
CAREER MANAGEMENT COMPETENCY AMONG VOCATIONAL SKILLED MILITARY RETIREES
932
Career management of business expatriates from China
933
Career mothers and perfectionism: stress at work and at home
934
CAREER MOVES: TRANSFER AND RANK CHALLENGE DECISIONS BY MALE LONG-TAILED MACAQUES
935
Career Obstacles of Working Women: A Research in Eskişehir
936
Career options in aerospace and aviation medicine
937
Career orientations and career success among research, and development and engineering professionals
938
Career orientations of information systems employees in South Africa
939
Career paths beyond nursing and the contribution of nursing experience and skills in attaining these positions
940
Career paths for the 21st century. How to beat job insecurity: Jim Duncan and David Oates, Century Business (1996), £12.99
941
Career Paths to Public Health: Programs at the Centers for Disease Control and Prevention Review Article
942
Career Perception at the Republic Indonesian Police Organization Impact of Distributive Fairness, Procedural Fairness and Career Satisfaction on Affective Commitment
943
Career planning and job searching in the information age : edited by Elizabeth A. Lorenzen. Binghampton, NY: Haworth Press, 1996 (simultaneously published as The Reference Librarian, no. 55). 120p. $29.95. ISBN 1-56024-838-6
944
CAREER PLANNING BY THE DOCTORS IN NWFP
945
Career plans and work perceptions of preservice teachers
946
Career plateauing and work attitudes: Moderating effects of mentoring others with Nigerian employees
947
Career preferences and the work–family balance in medicine: gender differences among medical specialists
948
Career profile of dentists in Saudi Arabia
949
Career progress of recent tourism graduates
950
Career prospects for female university researchers have not improved
951
Career Research Productivity Patterns of Marketing Academicians
952
Career Selection: Role of Parent’s Profession, Mass Media and Personal Choice
953
Career Self-Efficacy Among African-American Female Adolescents
954
Career skills gained from an international equine experience
955
Career stress responses among hospitality employees
956
Career Women as a Role Model in the Formation of Morals
957
Career, experience and returns to human capital: is the dual labour market hypothesis relevant for the UK?
958
Careers and clusters: analyzing the career network dynamic of biotechnology clusters
959
Careers and human resource management—a European perspective
960
Careers and lives socialization, structural lag, and gendered ambivalence
961
Careers and mortality in France: evidence on how far occupational mobility predicts differentiated risks
962
Careers in Medicine or what do you want when you grow up?
963
Careers in science: policy issues according to Nature and Science editorials
964
Careers in the next millennium: directions for future research
965
Careers within careers: Reconceptualizing the nature of career anchors and their consequence
966
Careful considerations when reporting and evaluating the grey water footprint of products
967
Careful Co-Planning for Effective Team Teaching in Mathematics
968
Careful naming of disorders
969
Careful partial harvesting in conservation stands and retention of large oaks favour oak regeneration Original Research Article
970
Care-full markets? A reply to John Christman and Veronica Crossa
971
Caregiver and peer responses to children with language and motor disabilities in inclusive preschool programs
972
Caregiver attributions are not just for children: Evidence for generalized low power schemas
973
Caregiver burden among Iranian heart failure family caregivers: A descriptive, exploratory, qualitative study
974
Caregiver burden among Japanese informal caregivers of cognitively impaired elderly in community settings
975
Caregiver Burden among Parents of Hearing Impaired and Intel- lectually Disabled Children in Pakistan
976
Caregiver burden and coping
977
Caregiver burden and disability in somatization disorder
978
Caregiver burden and health promotion
979
Caregiver Burden and Its Associated Factors in Caregivers of Children and Adolescents with Chronic Conditions
980
Caregiver Burden and its Determinants among the Family Members of Patients with Dementia in Iran
981
Caregiver burden and outcomes of caregiving of spouses of patients who undergo coronary artery bypass graft surgery
982
Caregiver Burden and Quality of Life among Caregivers of Cancer Patients in Ahvaz, 2021 - 2022: A Cross-Sectional Study
983
Caregiver burden and related factors in Iranian mothers of children with Attention-Deficit Hyperactivity Disorder
984
Caregiver burden associated with behavioral and psychological symptoms of dementia (BPSD) in Taiwanese elderly
985
Caregiver Burden in Primary Caregivers of Patients Undergone Hematopoietic Stem Cell Transplantation and Nursing Care
986
Caregiver commitment to foster children: The role of child behavior
987
Caregiver Low Health Literacy and Nonurgent Use of the Pediatric Emergency Department for Febrile Illness
988
Caregiver perspectives for the prevention, diagnosis and treatment of childhood giardiasis in Havana City, Cuba. A qualitative study
989
Caregiver Reciprocity: The effect of reciprocity, carer self-esteem and motivation on the experience of caregiver burden
990
Caregiver report in dementia: Contrasts with clinician perspective
991
Caregiver worry and injury hazards in the daily lives of Ugandan children
992
CAREGIVER´S EDUCATION LEVEL, NOT INCOME, AS DETERMINING FACTOR OF DIETARY INTAKE AND NUTRITIONAL STATUS OF INDIVIDUALS CARED FOR AT HOME
993
Caregiver’s Feeding Styles Questionnaire. Establishing cutoff points
994
Caregiver’s needs as predictors of hospital readmission for the elderly in Taiwan
995
Caregiver-coping in bipolar disorder and schizophrenia
996
Caregiver-mother partnership behavior and the quality of caregiver-child and mother-child interactions
997
Caregivers Expressed Emotion in Response to Patient Psychiatric Symptoms
998
Caregiverʹs burden, depression and support as predictors of post-stroke depression: a cross-sectional survey
999
Caregiversʹ experiences of caring for a husband with Parkinsonʹs disease and psychotic symptoms
1000
Caregivers of children with sexual behavior problems: Psychological and familial functioning
بازگشت